Bioverge, Inc. is a US-based venture capital firm specializing in emerging healthcare startups. The firm typically invests in seed, Series A, and Series B rounds, with a focus on innovative companies in the healthcare sector. Bioverge aims to support early-stage ventures that are poised to make significant advancements in medical technology and healthcare solutions.
Notable portfolio companies include Aspen Neuroscience, Eigen Therapeutics, Elucid Bioimaging, EnClear Therapies, Juno Diagnostics, Modulo Bio, Notable Labs, NutriSense, OccamzRazor, and Octant. Bioverge's investment philosophy centers on fostering groundbreaking healthcare innovations. The firm offers unique value-add services to its portfolio companies, leveraging deep industry expertise and a robust network to accelerate growth and development.
Bioverge - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages